Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Lung Neoplasm”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01644994
What this trial is testing

Intracavitary Cisplatin-Fibrin Localized Chemotherapy After P/D or EPP for Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
University of Zurich 47
Not applicableLooking for participantsNCT05538806
What this trial is testing

TTFields in General Routine Clinical Care in Patients With Pleural Mesothelioma Study

Who this might be right for
Pleural Mesothelioma
NovoCure Ltd. 198
Testing effectiveness (Phase 2)UnknownNCT04982900
What this trial is testing

Treatment of EGFR-TKI for Residual Lesions of Multiple Synchronous Ground-glass Opacities

Who this might be right for
Multiple Primary Lung Cancers
Ruijin Hospital 138
Testing effectiveness (Phase 2)WithdrawnNCT02661100
What this trial is testing

A Trial of CDX-1401 in Combination With Poly-ICLC and Pembrolizumab, in Previously Treated Advanced Solid Tumor Patients

Who this might be right for
Non Small Cell Lung CancerAdvanced Triple Negative Breast CancerSmall Cell Lung Cancer+3 more
Case Comprehensive Cancer Center
Not applicableActive Not RecruitingNCT04761107
What this trial is testing

Impact of COVID-19 on GU Disease

Who this might be right for
COVID-19 InfectionGenitourinary CancerBenign Urologic Conditions
Icahn School of Medicine at Mount Sinai 15,240
Testing effectiveness (Phase 2)Active Not RecruitingNCT03899792
What this trial is testing

Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) Tumors

Who this might be right for
Medullary Thyroid CancerInfantile MyofibromatosisInfantile Fibrosarcoma+2 more
Eli Lilly and Company 36
Early research (Phase 1)Active Not RecruitingNCT02595931
What this trial is testing

M6620 and Irinotecan Hydrochloride in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

Who this might be right for
Metastatic Colorectal CarcinomaMetastatic Lung Small Cell CarcinomaMetastatic Malignant Solid Neoplasm+15 more
National Cancer Institute (NCI) 66
Not applicableLooking for participantsNCT00991094
What this trial is testing

Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy

Who this might be right for
Breast CarcinomaEsophageal CarcinomaGenitourinary System Carcinoma+6 more
M.D. Anderson Cancer Center 5,000
Early research (Phase 1)Study completedNCT04040231
What this trial is testing

Using a Targeted Cancer Vaccine (Galinpepimut-S) With Immunotherapy (Nivolumab) in Mesothelioma

Who this might be right for
MesotheliomaPleural MesotheliomaWilms Tumor
Memorial Sloan Kettering Cancer Center 10
Not applicableStudy completedNCT05058339
What this trial is testing

Distress Associated with Coronavirus Disease 2019 and Telehealth on Supportive Care Patients with Advanced Cancer

Who this might be right for
Advanced Malignant Solid NeoplasmCOVID-19 InfectionHematopoietic and Lymphoid Cell Neoplasm+4 more
M.D. Anderson Cancer Center 223
Not applicableLooking for participantsNCT06037941
What this trial is testing

Using E-Nose Technology to Measure Response to Treatment in People With Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
Memorial Sloan Kettering Cancer Center 20
Not applicableLooking for participantsNCT04551378
What this trial is testing

The Effect of COVID-19 Pandemic on Adolescent and Young Adult Cancer Patients and Survivors

Who this might be right for
COVID-19 InfectionHematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
M.D. Anderson Cancer Center 600
Large-scale testing (Phase 3)Study completedNCT02585713
What this trial is testing

Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism

Who this might be right for
Cerebral Vein ThrombosisDeep Vein ThrombosisGonadal Thrombosis+9 more
Academic and Community Cancer Research United 300
Testing effectiveness (Phase 2)Active Not RecruitingNCT04195555
What this trial is testing

Ivosidenib in Treating Patients With Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With IDH1 Mutations (A Pediatric MATCH Treatment Trial)

Who this might be right for
Recurrent EpendymomaRecurrent Ewing SarcomaRecurrent Hepatoblastoma+30 more
National Cancer Institute (NCI) 3
Not applicableLooking for participantsNCT07561190
What this trial is testing

Multidimensional Omics Analysis in Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma (MPM)
Azienda USL Reggio Emilia - IRCCS 300
Large-scale testing (Phase 3)Study completedNCT02321397
What this trial is testing

To Demonstrate Equivalence in Analgesic Efficacy & Bowel Function Between OXN PR Higher Dose & Lower Dose Tablet Strengths in Subjects With Non-cancer or Cancer Pain

Who this might be right for
Malignant PainNon-malignant Pain
Mundipharma Research GmbH & Co KG 155
Not applicableUnknownNCT05042557
What this trial is testing

Real World Study of MPM in China

Who this might be right for
Malignant Pleural MesotheliomaDiagnoses DiseaseTreatments+1 more
Chinese Academy of Medical Sciences 500
Large-scale testing (Phase 3)Active Not RecruitingNCT06097728
What this trial is testing

MEDI5752 in Combination With Carboplatin Plus Pemetrexed in Unresectable Pleural Mesothelioma

Who this might be right for
Unresectable Pleural Mesothelioma
AstraZeneca 863
Not applicableUnknownNCT00336609
What this trial is testing

TRIAD Burden of Illness Mucositis Study

Who this might be right for
Gastrointestinal Mucositis (Defined as Mucositis Involving the Mouth, Esophagus, or Small Intestine)
TRIAD Burden of Illness 1,600
Testing effectiveness (Phase 2)UnknownNCT03475953
What this trial is testing

A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors

Who this might be right for
Colorectal Cancer Not MSI-H or MMR-deficientGISTOesophageal or Gastric Carcinoma+12 more
Institut Bergonié 747
Next Page